KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$17.5 million.

  • Cme's Change in Account Payables fell 15833.33% to -$17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.0 million, marking a year-over-year decrease of 17236.84%. This contributed to the annual value of -$10.7 million for FY2024, which is 6525.97% up from last year.
  • As of Q3 2025, Cme's Change in Account Payables stood at -$17.5 million, which was down 15833.33% from -$7.8 million recorded in Q2 2025.
  • In the past 5 years, Cme's Change in Account Payables ranged from a high of $36.7 million in Q4 2023 and a low of -$50.0 million during Q4 2024
  • Its 5-year average for Change in Account Payables is $411111.1, with a median of -$2.4 million in 2023.
  • The largest annual percentage gain for Cme's Change in Account Payables in the last 5 years was 93448.28% (2024), contrasted with its biggest fall of 23623.98% (2024).
  • Over the past 5 years, Cme's Change in Account Payables (Quarter) stood at -$22.2 million in 2021, then soared by 218.47% to $26.3 million in 2022, then skyrocketed by 39.54% to $36.7 million in 2023, then plummeted by 236.24% to -$50.0 million in 2024, then surged by 65.0% to -$17.5 million in 2025.
  • Its Change in Account Payables was -$17.5 million in Q3 2025, compared to -$7.8 million in Q2 2025 and $20.3 million in Q1 2025.